Zoldonat (Zoledronic Acid) 4 mg — 1 Vial
Zoldonat is a potent bisphosphonate injection used in oncology care. Active ingredient: Zoledronic Acid (4 mg).
Manufacturer: Natco Pharma (India). Generic equivalent of Zometa.
Mechanism of Action:
It inhibits osteoclast activity, effectively stopping the breakdown of bone tissue. In cancer patients with bone metastases, Zoldonat strengthens the bones, reduces pain, and prevents serious skeletal complications like fractures.
✅ Key Benefit: Reduces the risk of Skeletal Related Events (SREs) in patients with advanced malignancies involving bone.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 13.03.2026
What Customers Say
No reviews yet
Your review can be the first!